High dose cyclophosphamide (CY) for severe aplastic anemia (SAA): Safety and long term follow-up.

被引：0
|
作者：
Brodsky, RA
Chen, A
Dorr, DM
Brodsky, I
Jones, RJ
机构：
[1] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA
[2] Drexel Univ, Philadelphia, PA 19104 USA
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
129
引用
收藏
页码：41A / 42A
页数：2
相关论文
共 50 条
  • [1] High-dose cyclophosphamide (CY) for acquired severe aplastic anemia (SAA): Long-term follow-up in 56 patients
    Brodsky, RA
    EXPERIMENTAL HEMATOLOGY, 2003, 31 (07) : 102 - 102
  • [2] Immunopathogenesis of severe aplastic anemia (SAA): Impact of high dose cyclophosphamide (CY).
    Brodsky, RA
    Hess, AD
    Thoburn, C
    Bright, E
    Barber, JP
    Jones, RJ
    BLOOD, 2002, 100 (11) : 9A - 10A
  • [3] High-dose cyclophosphamide for severe aplastic anemia: long-term follow-up
    Brodsky, Robert A.
    Chen, Allen R.
    Dorr, Donna
    Fuchs, Ephraim J.
    Huff, Carol Ann
    Luznik, Leo
    Smith, B. Douglas
    Matsui, William H.
    Goodman, Steven N.
    Ambinder, Richard F.
    Jones, Richard J.
    BLOOD, 2010, 115 (11) : 2136 - 2141
  • [4] Late complications following treatment for severe aplastic anemia (SAA) with high-dose cyclophosphamide (Cy):: follow-up of a randomized trial
    Tisdale, JF
    Maciejewski, JP
    Nuñez, O
    Rosenfeld, SJ
    Young, NS
    BLOOD, 2002, 100 (13) : 4668 - 4670
  • [5] High-dose cyclophosphamide (Cy) without bone marrow transplant in the treatment of children with severe aplastic anemia (SAA).
    González-Llano, O
    Jaime-Pérez, JC
    Herrera-Garza, JL
    Gómez-Almaguer, D
    BLOOD, 1998, 92 (10) : 16B - 16B
  • [6] High-dose cyclophosphamide (Cy) without bone marrow transplant (BMT) for newly diagnosed or refractory severe aplastic anemia (SAA).
    Brodsky, RA
    Smith, BD
    Chen, A
    Doeblin, TD
    Dorr, D
    Brodsky, I
    Jones, RJ
    BLOOD, 1997, 90 (10) : 1952 - 1952
  • [7] LONG-TERM FOLLOW-UP OF SEVERE APLASTIC-ANEMIA (SAA) PATIENTS TREATED WITH IMMUNOSUPPRESSION (IS)
    DEPLANQUE, MM
    BACIGALUPO, A
    WURSCH, A
    FRICKHOFEN, N
    GLUCKMAN, E
    NISSEN, C
    GORDONSMITH, EC
    BONE MARROW TRANSPLANTATION, 1988, 3 : 239 - 239
  • [8] Bone marrow transplantation in multiply transfused patients with severe aplastic anemia (SAA) using cyclophosphamide (CY) and total lymphoid irradiation (TLI) for conditioning: Long-term follow-up
    Gaziev, J
    Giardini, C
    Galimberti, M
    Angelucci, E
    Polchi, P
    Baronciani, D
    Erer, B
    Sotti, G
    Lucarelli, G
    BONE MARROW TRANSPLANTATION, 1999, 23 : S29 - S29
  • [9] A randomized trial comparing antithymocyte globulin and cyclosporin to cyclophosphamide and cyclosporin for initial treatment in severe aplastic anemia: Results of long-term follow-up.
    Tisdale, JF
    Maciejewski, JP
    Nunez, O
    Rosenfeld, SJ
    Young, NS
    BLOOD, 2001, 98 (11) : 223A - 223A
  • [10] High-dose cyclophosphamide (Cy) without allogeneic bone marrow transplant (BMT) produces durable complete remissions in severe aplastic anemia (SAA).
    Brodsky, RA
    Smith, BD
    Brodsky, I
    Jones, RJ
    BLOOD, 1999, 94 (10) : 674A - 674A
12345